U.S. Markets closed

Innovus Pharmaceuticals, Inc. (INNV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.12+0.01 (+9.55%)
At close: 3:57PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 518.06M
Enterprise Value 3N/A
Trailing P/E -0.90
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.67
Price/Book (mrq)6.00
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profit Margin -217.00%
Operating Margin (ttm)-91.72%
Management Effectiveness
Return on Assets (ttm)-48.51%
Return on Equity (ttm)-1,643.46%
Income Statement
Revenue (ttm)6.77M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)865.70%
Gross Profit (ttm)3.74M
Net Income Avi to Common (ttm)-14.69M
Diluted EPS (ttm)-0.13
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)2.38M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)802.05k
Total Debt/Equity (mrq)26.32
Current Ratio (mrq)0.96
Book Value Per Share (mrq)0.02
Cash Flow Statement
Operating Cash Flow (ttm)-2.17M
Levered Free Cash Flow (ttm)-1.12M

Trading Information

Stock Price History
Beta 4.27
52-Week Change 3-52.37%
S&P500 52-Week Change 319.49%
52 Week High 30.66
52 Week Low 30.08
50-Day Moving Average 30.12
200-Day Moving Average 30.15
Share Statistics
Avg Vol (3 month) 3828.95k
Avg Vol (10 day) 3585.98k
Shares Outstanding 5150.54M
Float 103.55M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A